Published in Biophys Rev on June 01, 2012
Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol (2015) 1.52
Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro. J Muscle Res Cell Motil (2012) 1.14
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C. Front Physiol (2013) 0.95
Earning stripes: myosin binding protein-C interactions with actin. Pflugers Arch (2014) 0.92
Length-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation. Front Physiol (2014) 0.90
Cardiac myosin binding protein-C: a novel sarcomeric target for gene therapy. Pflugers Arch (2013) 0.90
Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells. Proc Natl Acad Sci U S A (2014) 0.89
A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay. J Vis Exp (2013) 0.86
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch (2013) 0.85
Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function. PLoS One (2013) 0.84
Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium. Proteomics Clin Appl (2014) 0.82
Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships. Pflugers Arch (2013) 0.81
Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function. Arch Biochem Biophys (2016) 0.80
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy. World J Diabetes (2015) 0.80
Cardiac myosin binding protein C phosphorylation affects cross-bridge cycle's elementary steps in a site-specific manner. PLoS One (2014) 0.79
Quantitative phosphoproteomics using acetone-based peptide labeling: method evaluation and application to a cardiac ischemia/reperfusion model. J Proteome Res (2013) 0.78
The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C. Transl Res (2015) 0.78
Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice. Am J Physiol Heart Circ Physiol (2016) 0.77
A change of heart: oxidative stress in governing muscle function? Biophys Rev (2015) 0.75
MYBPC1, an Emerging Myopathic Gene: What We Know and What We Need to Learn. Front Physiol (2016) 0.75
Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome. JACC Basic Transl Sci (2016) 0.75
A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization. J Mol Biol (1973) 4.79
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science (2011) 4.36
Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J Mol Biol (1994) 3.57
Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res (1999) 3.43
Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res (2000) 3.32
Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J (1995) 3.28
Nectin and afadin: novel organizers of intercellular junctions. J Cell Sci (2003) 3.19
Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res (2002) 2.82
Towards a molecular understanding of titin. EMBO J (1992) 2.78
A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet (2009) 2.67
Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res (2005) 2.67
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63
Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ Res (2006) 2.50
Myofilament length dependent activation. J Mol Cell Cardiol (2010) 2.47
Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc Natl Acad Sci U S A (2006) 2.46
Three-dimensional structure of vertebrate cardiac muscle myosin filaments. Proc Natl Acad Sci U S A (2008) 2.39
Cardiac myosin binding protein C: its role in physiology and disease. Circ Res (2004) 2.38
A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem (1996) 2.34
Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol (2009) 2.32
Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol (1999) 2.27
cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett (1999) 2.16
The myosin-binding protein C motif binds to F-actin in a phosphorylation-sensitive manner. J Biol Chem (2009) 2.16
Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations. Circ Res (2002) 2.13
Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res (2007) 2.11
Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium. Circ Res (2006) 2.10
The binding of skeletal muscle C-protein to F-actin, and its relation to the interaction of actin with myosin subfragment-1. J Mol Biol (1978) 2.09
Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res (2005) 2.08
Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ Res (2008) 2.07
Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain. J Mol Biol (2003) 2.04
Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci U S A (1996) 2.02
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest (1999) 2.02
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation (2009) 2.01
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol (2001) 1.97
Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res (1999) 1.96
Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res (1998) 1.92
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol (2007) 1.85
Cardiac myosin-binding protein C decorates F-actin: implications for cardiac function. Proc Natl Acad Sci U S A (2008) 1.84
Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscle. Proc Natl Acad Sci U S A (2011) 1.83
Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay: Evidence for long-lived cross-bridges. J Biol Chem (2006) 1.81
In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res (2011) 1.81
Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J (1988) 1.73
Isolation and characterization of a cDNA clone encoding avian skeletal muscle C-protein: an intracellular member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1990) 1.71
Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites. Arch Biochem Biophys (1998) 1.69
Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. Biophys J (2006) 1.69
Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci U S A (1997) 1.68
Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle. J Mol Cell Cardiol (2010) 1.67
Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts-- evidence for novel phosphorylation sites. Proteomics (2006) 1.65
A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.65
Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol (2003) 1.62
A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function. Circ Res (2011) 1.61
Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation (2005) 1.59
Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. J Mol Cell Cardiol (2001) 1.59
Understanding the organisation and role of myosin binding protein C in normal striated muscle by comparison with MyBP-C knockout cardiac muscle. J Mol Biol (2008) 1.57
Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation. Circulation (2007) 1.55
Protein kinase A-mediated phosphorylation of cMyBP-C increases proximity of myosin heads to actin in resting myocardium. Circ Res (2008) 1.55
Thin filament mutations: developing an integrative approach to a complex disorder. Circ Res (2011) 1.55
Small-angle X-ray scattering reveals the N-terminal domain organization of cardiac myosin binding protein C. J Mol Biol (2008) 1.53
Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res (2009) 1.52
Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background. Circulation (2009) 1.52
Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C. Biophys J (2001) 1.52
Polypeptide chains of intermediate molecular weight in myosin preparations. FEBS Lett (1971) 1.50
Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ Res (1998) 1.50
Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res (2007) 1.50
Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J Biol Chem (2009) 1.47
Phosphorylation of a myofibrillar protein of Mr 150 000 in perfused rat heart, and the tentative indentification of this as C-protein. FEBS Lett (1980) 1.44
Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain. J Mol Cell Cardiol (2011) 1.40
Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. Cardiovasc Res (2004) 1.39
Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II. J Biol Chem (1991) 1.37
Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C (cMyBP-C). J Mol Biol (2011) 1.37
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. J Mol Cell Cardiol (2008) 1.36
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Radial displacement of myosin cross-bridges in mouse myocardium due to ablation of myosin binding protein-C. J Mol Biol (2006) 1.33
Binding of myosin binding protein-C to myosin subfragment S2 affects contractility independent of a tether mechanism. Circ Res (2004) 1.33
Structure and interactions of myosin-binding protein C domain C0: cardiac-specific regulation of myosin at its neck? J Biol Chem (2011) 1.31
Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res (2001) 1.30
Fluorescence microscope study of the binding of added C protein to skeletal muscle myofibrils. J Cell Biol (1981) 1.30
Identification of novel protein kinase A phosphorylation sites in the M-domain of human and murine cardiac myosin binding protein-C using mass spectrometry analysis. J Proteome Res (2010) 1.28
Myosin binding protein C interaction with actin: characterization and mapping of the binding site. J Biol Chem (2010) 1.27
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol (2011) 1.27
A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation (2000) 1.26
Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res (2009) 1.26
Binding of the N-terminal fragment C0-C2 of cardiac MyBP-C to cardiac F-actin. J Struct Biol (2010) 1.26
Dissecting the N-terminal myosin binding site of human cardiac myosin-binding protein C. Structure and myosin binding of domain C2. J Biol Chem (2006) 1.25
The binding of skeletal muscle C-protein to regulated actin. FEBS Lett (1986) 1.24
Myosin binding protein C positioned to play a key role in regulation of muscle contraction: structure and interactions of domain C1. J Mol Biol (2008) 1.22
The C-proteins of rabbit red, white, and cardiac muscles. J Biol Chem (1983) 1.22
Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models. Am J Physiol Heart Circ Physiol (2009) 1.21
Myosin head orientation: a structural determinant for the Frank-Starling relationship. Am J Physiol Heart Circ Physiol (2011) 1.21
Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment. Eur J Biochem (1993) 1.20
Complete primary structure of chicken cardiac C-protein (MyBP-C) and its expression in developing striated muscles. J Mol Cell Cardiol (1995) 1.18
Signaling and myosin-binding protein C. J Biol Chem (2011) 1.18
Kettin, a large modular protein in the Z-disc of insect muscles. EMBO J (1993) 1.17
Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res (1999) 1.16
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res (2009) 1.16
Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length human cDNA. J Cell Sci (1992) 1.15
The role of thin filament cooperativity in cardiac length-dependent calcium activation. Biophys J (2010) 1.15
Titin isoform switch in ischemic human heart disease. Circulation (2002) 3.05
Myofilament calcium sensitivity in skinned rat cardiac trabeculae: role of interfilament spacing. Circ Res (2002) 2.53
Approximate model of cooperative activation and crossbridge cycling in cardiac muscle using ordinary differential equations. Biophys J (2008) 2.29
Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res (2007) 2.05
Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem (2003) 1.99
Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol (2003) 1.85
Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res (2003) 1.82
Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem (2008) 1.75
The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res (2007) 1.74
Impact of beta-myosin heavy chain isoform expression on cross-bridge cycling kinetics. Am J Physiol Heart Circ Physiol (2004) 1.67
Cooperative activation in cardiac muscle: impact of sarcomere length. Am J Physiol Heart Circ Physiol (2002) 1.61
Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch (2007) 1.52
p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ Res (2007) 1.48
Beneficial effects of SR33805 in failing myocardium. Cardiovasc Res (2011) 1.43
Length-dependent activation in three striated muscle types of the rat. J Physiol (2002) 1.37
Frank-Starling law of the heart and the cellular mechanisms of length-dependent activation. Pflugers Arch (2002) 1.34
Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased? J Mol Cell Cardiol (2008) 1.31
Impact of osmotic compression on sarcomere structure and myofilament calcium sensitivity of isolated rat myocardium. Am J Physiol Heart Circ Physiol (2006) 1.30
Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol (2006) 1.25
Restoration of resting sarcomere length after uniaxial static strain is regulated by protein kinase Cepsilon and focal adhesion kinase. Circ Res (2004) 1.24
Myosin head orientation: a structural determinant for the Frank-Starling relationship. Am J Physiol Heart Circ Physiol (2011) 1.21
Approaches to modeling crossbridges and calcium-dependent activation in cardiac muscle. Prog Biophys Mol Biol (2004) 1.19
Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium. J Physiol (2007) 1.18
Cardiac troponin I threonine 144: role in myofilament length dependent activation. Circ Res (2007) 1.18
Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem (2008) 1.15
Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein. Am J Physiol Heart Circ Physiol (2006) 1.15
The role of thin filament cooperativity in cardiac length-dependent calcium activation. Biophys J (2010) 1.15
Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro. J Muscle Res Cell Motil (2012) 1.14
Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ Res (2005) 1.14
Cardiac thin filament regulation. Pflugers Arch (2008) 1.13
Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. Cardiovasc Res (2008) 1.12
Depressed cardiac myofilament function in human diabetes mellitus. Am J Physiol Heart Circ Physiol (2005) 1.11
Ising model of cardiac thin filament activation with nearest-neighbor cooperative interactions. Biophys J (2003) 1.10
Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice. J Biol Chem (2010) 1.07
Actin capping protein: an essential element in protein kinase signaling to the myofilaments. Circ Res (2002) 1.02
Differential contribution of cardiac sarcomeric proteins in the myofibrillar force response to stretch. Pflugers Arch (2008) 0.99
Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation. Circ Res (2002) 0.99
Myosin binding protein C in the heart. Circ Res (2006) 0.98
Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. J Clin Invest (2014) 0.97
Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol (2004) 0.94
Cardiac myosin binding protein-C as a central target of cardiac sarcomere signaling: a special mini review series. Pflugers Arch (2013) 0.93
Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism. Am J Physiol Heart Circ Physiol (2005) 0.93
Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2014) 0.92
Interfilament spacing is preserved during sarcomere length isometric contractions in rat cardiac trabeculae. Biophys J (2007) 0.91
Control of cardiac myofilament activation and PKC-betaII signaling through the actin capping protein, CapZ. J Mol Cell Cardiol (2006) 0.90
Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium. J Biol Chem (2014) 0.90
Novel approaches to determine contractile function of the isolated adult zebrafish ventricular cardiac myocyte. J Physiol (2014) 0.89
Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation. J Muscle Res Cell Motil (2011) 0.89
Myofilament length-dependent activation develops within 5 ms in guinea-pig myocardium. Biophys J (2012) 0.89
Mechanisms of Ca²+ handling in zebrafish ventricular myocytes. Pflugers Arch (2013) 0.89
Interventricular differences in myofilament function in experimental congestive heart failure. Pflugers Arch (2011) 0.87
Impact of titin isoform on length dependent activation and cross-bridge cycling kinetics in rat skeletal muscle. Biochim Biophys Acta (2012) 0.86
Development of contractile dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Regul Integr Comp Physiol (2007) 0.84
New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I. Biochim Biophys Acta (2012) 0.83
Glass microneedles for force measurements: a finite-element analysis model. Pflugers Arch (2008) 0.83
Physiological significance of troponin T binding domains in striated muscle tropomyosin. Am J Physiol Heart Circ Physiol (2004) 0.82
Some rat: a very special rat with a rather special titin. J Mol Cell Cardiol (2008) 0.81
Equal force recovery in dysferlin-deficient and wild-type muscles following saponin exposure. J Biomed Biotechnol (2011) 0.79
The cytoskeleton and the cellular transduction of mechanical strain in the heart: a special issue. Pflugers Arch (2011) 0.77
Heart failure: a special issue. Pflugers Arch (2014) 0.76
Titin and the developing heart. Circ Res (2004) 0.75
Rapid exchange of actin-bound nucleotide in perfused rat heart. Am J Physiol Heart Circ Physiol (2004) 0.75
Sex differences in health and disease: brain and heart connections--a special issue. Pflugers Arch (2013) 0.75